RxDoctor Payments Data

Michael Blackmer, DO

Adult Reconstructive Orthopaedic Surgery · Foley, ALNPI 1194141333

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,711 of the $5,063 with a category attached, or 73.3%. 20 manufacturers reported payments, led by Smith+Nephew at 27.9% of the total. 2025 is the largest year on record at $2,046, more than ten times the $124 reported in 2019.

$5,063in general payments, 2019–2025

Across 73 payments — averaging $69.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$1K
  • Zimmer Biomet$910
  • Stryker$804
  • Johnson & Johnson$386
  • DJO, LLC$324
  • Medacta USA, Inc.$206
  • plus $1K from 14 others

What the payments were for

  • Travel & lodging$4739%
  • Food & beverage$3,71173%
  • Education$87517%
  • Gifts$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Alabamato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$402,810
Medicare patients
614
Services billed
6,963

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban16$8,446
Oxycodone Hcl457$2,418
Celecoxib92$2,043
Pregabalin228$1,907
Methylprednisolone226$1,804
Mupirocin244$1,692
Diclofenac Sodium108$1,619
Meloxicam316$861
Doxycycline Hyclate51$740
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen77$593
Esomeprazole Magnesium29$465
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen47$307
Tramadol Hcl61$205
Cyclobenzaprine Hcl32$152
Ondansetron OdtOndansetron14$151

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Foley

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →